Novartis Q2 Beat Signals Stability for Healthcare ETFs This Week

Novartis, a major pharmaceutical firm, has delivered a robust second-quarter performance, with both earnings and revenue figures exceeding market estimates. This development, announced on July 21, 2026, offers a significant data point for investors assessing…